Search results
Europe Recommends Three Cancer Drugs
Medscape· 1 day agoThe European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Alcohol use is widely accepted in the US, but even moderate consumption is associated with many...
The Conversation via Yahoo News· 25 minutes agoThat trial was designed to pick up the heart benefits of consuming one drink a day, but was not...
MDH and Everest: US health officials probe Indian spice mix pesticide claims
BBC via Yahoo News· 2 hours ago[Getty Images] The US Food and Drug Administration is looking into products made by two Indian spice...
Oncologists' meetings with drug reps don't help cancer patients live longer
KTEP 88.5 El Paso· 5 days agoPharmaceutical company reps have been visiting doctors for decades to tell them about the latest...
Patient, 59, 'at death's door' before cancer drug ‘eradicated’ disease in months
The US Sun· 4 days agoA MAN "at death's door" after running out of treatment options for leukaemia became the second...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 21 hours agoA trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 1 day agoWatch: World's first skin cancer drug being tested in UK patients A man has revealed how his “bump...
King Charles: What kind of cancer treatment is available to him - and what impact could it have
The Independent via Yahoo News· 20 hours agoThe drugs seek to disrupt the way cancer cells grow and drive but can also damage some of the health...
Cancer drug trial provides lessons for future
Medical Xpress· 2 days agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal ...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 1 day agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...